close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about IBB

Recent news which mentions IBB

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
Tickers ABBV ABMD AMLX ARWR
Tags Top Stories News IBB
From Benzinga
3 Growth ETFs to Consider Buying During This Correction
Tickers BNTX CURLF EDIT GILD
Tags TCNNF GTBIF MRNA
From Motley Fool
Why Sorrento Therapeutics Stock Is Getting Hammered This Week
Tickers IBB SRNE XBI
Tags IBB XBI Recent Press Releases
From Motley Fool
The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicron
Tickers ALXO BGNE BIIB IBB
Tags Benzinga MRK Small Cap
From Benzinga
J&J exec says biotechs aren’t ‘necessarily on sale’ even after a challenging 2021
Tickers BNTX DRG IBB JNJ
Tags SPX DRG PFE
From MarketWatch
The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study
Tickers ARDS ATAI ATRA CUE
Tags Benzinga CUE MRK
From Benzinga
The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data
Tickers ABT BMY CUE EW
Tags Benzinga Small Cap NRXP
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data
Tickers AMRN BNTX CAPR ETNB
Tags JNJ Benzinga PFE
From Benzinga
The Week Ahead In Biotech (Jan 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, Samsara Vision IPO And More
Tickers ABT CUE DCPH ETON
Tags CUE Benzinga JNJ
From Benzinga
The Daily Biotech Pulse: Kura Lifts Clinical Hold On Blood Cancer Trial, Intuitive Surgical Earnings, Sorrento's Omicron Antibody Treatment Effective
Tickers ABUS ALNY ASLN IBB
Tags Small Cap Benzinga SNOA
From Benzinga
The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug
Tickers ALKS AMGN ARGX BGNE
Tags General IBB ARGX
From Benzinga
The Daily Biotech Pulse: Gamida Gains On Positive Regulatory Development, Orphazyme & ADMA Preannouncements, ImmunityBio & Leap Present Positive Data
Tickers ADMA ASLN BGNE CRDF
Tags Biotech IBRX Guidance
From Benzinga
The Week Ahead In Biotech (Jan 16-22): Focus On Data Presentations And IPOs In Holiday-Shortened Week
Tickers ALNY ASLN AZN CRDF
Tags Earnings MODD AZN
From Benzinga
Get ready for the climb. Here’s what history says about stock-market returns during Fed rate-hike cycles.
Tickers AAL AMC ARKF ARKG
Tags SPX KMI DJIA
From MarketWatch
The Daily Biotech Pulse: Bausch Files For Eye Health Unit IPO, LumiraDx Antigen Test Can Detect Omicron, Molecular Partners Discloses Fund Stake
Tickers BHC CRVS CSII IBB
Tags BHC News Market News
From Benzinga
The Daily Biotech Pulse: Adagio's Antibody Effective Against Omicron, Sarepta Terminates Gene Therapy Deal, AstraZeneca Inks Oncology Pact
Tickers ADAG ADGI AZN BMY
Tags NRXP CANF RLFTF
From Benzinga
The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award
Tickers ACRS ATAI BIIB BNTX
Tags BYSI HILS PFE
From Benzinga
The Daily Biotech Pulse: Illunina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In
Tickers AZN BCAB BDTX BMY
Tags Small Cap Benzinga SSKN
From Benzinga
The Week Ahead In Biotech (Jan 10-15): JPMorgan Healthcare Conference Front And Center, Preannouncements Keep Coming
Tickers ALGS BNOX BNTX GNTA
Tags IPOs JPM FDA
From Benzinga
The Daily Biotech Pulse: Glaukos Gets FDA Nod, Neurocrine Preannounces Soft Ingrezza Sales, 3 IPOs
Tickers AMLX CINC FDMT GKOS
Tags Benzinga HEPA CINC
From Benzinga
The Daily Biotech Pulse: Lilly Strikes Neurological R&D Collaboration, Valneva Confirms Vaccine Timelines, Biohaven Gains On Strong Migraine Drug Sales
Tickers AVTX BHVN CNSP IBB
Tags CNSP BHVN Penny Stocks
From Benzinga
Consolidation Could Come Calling for Biotech in 2022
Tickers BBC BBH IBB SBIO
Tags virtus investment partners SS&C ALPS
From ETF Trends
The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets
Tickers AMRX ANGN ANNX BDSX
Tags BNTX ANNX Financing
From Benzinga
The Daily Biotech Pulse: Liquidia Jumps On New CEO Appointment, Spectrum, Aravive Secure New Funding, Allena To Explore Strategic Alternatives
Tickers ALNA AMGN ARAV AVRO
Tags Small Cap Benzinga PSTV
From Benzinga
The Week Ahead In Biotech (Jan 2-Jan. 8): Stray Clinical Readouts In Focus In Slow News Week
Tickers AVTX AZN BBIO EWTX
Tags Benzinga AZN Small Cap
From Benzinga
Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates
Tickers ALNY ETON IBB NVS
Tags Trading Ideas SNY PFE
From Benzinga
Biotech M&A Could Finally Perk Up in 2022
Tickers BBC BBH IBB SBIO
Tags SBIO BlackRock ETF Building Blocks Channel
From ETF Trends
The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year
Tickers ADAG ALLK AVTX AVXL
Tags VNDA Small Cap PFE
From Benzinga
The Daily Biotech Pulse: Novartis Snags Twin FDA Nods, Novavax Positive Vaccine News Continues, Arcutis Psoriasis Application Accepted For Review
Tickers ADAG ALNY ARQT EXEL
Tags Small Cap Benzinga VSTM
From Benzinga
The Daily Biotech Pulse: Allakos Slips Negative Late-Stage Data, Pfizer & Merck Announce Fresh COVID Pill Deal With UK, Regulatory Setback For Takeda
Tickers ALLK GILD GRFS IBB
Tags TYRA Market News Top Stories
From Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today